Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43,411,663
-
Total 13F shares
-
6,080,606
-
Share change
-
+1,578,714
-
Total reported value
-
$51,262,809
-
Price per share
-
$8.43
-
Number of holders
-
44
-
Value change
-
+$13,288,944
-
Number of buys
-
30
-
Number of sells
-
8
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q3 2019
As of 30 Sep 2019,
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,080,606 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, BlackRock Inc., Slate Path Capital LP, VANGUARD GROUP INC, 683 Capital Management, LLC, STATE STREET CORP, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, Nuveen Asset Management, LLC, and HSBC HOLDINGS PLC.
This page lists
44
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.